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Substance use disorder is a condition that affects the brain and results in the inability of a 
person to manage their substance use.  Approximately 9% of adolescents and young 
adults in the United States suffer from a substance use disorder, and the majority that 
receive treatment relapse within 6 months. Adolescents and young adults, especially 
those with low socioeconomic status, have access to fewer resources for treatment. In 
this study, we will assess an accessible computer-based cognitive behavioral therapy 
for treatment in adolescents and young adults with substance use disorders as an 
efficacious and durable treatment. We will use a prospective, randomized control trial  
to examine the percentage of drug-negative urine in young adults and adolescents with 
substance use disorder whose initial treatment includes Computer Based Training for 
Cognitive Behavioral Therapy (CBT4CBT).  Our goal is to expand access to treatment 






1. Chapter 1 Introduction 
1.1 Overview 
1.1.1 Adolescents and Young Adults with Substance Use Disorders 
One of the most prevalent healthcare-related issues in the twenty-first century has been 
the overwhelming increase in substance use. In the United States, over 4% of adolescents 
(age 12-17) and 4.8% of young adults (ages 18-25) suffer from a substance use disorder. 
In addition, on average less than 5.7% of these people decided to pursue treatment for their 
disorder. 1 While there are numerous factors that play a role in the low percentage of people 
seeking treatment, a few stand out. These factors include the cost of the treatment, 
accessibility, and social stigma. 2,3 The initial standard treatment that most are referred to 
is a combination of group therapy, rehabilitation centers and the use of pharmacology.1 
Unfortunately, all of these methods fail to consistently address the main concerns of 
adolescent and young adult patients entering treatment. Rehabilitation centers are 
notoriously expensive, group therapy offers little protection from social stigma, and 
pharmacology can be expensive and hard to access. 2  In addition to this, unfortunately, 
more than 85% of patients will relapse and return to substance use within one year after 
treatment. 4 These statistics clearly show that treatment should be aiming to meet the needs 
of adolescents and young adults as an individual, and alternative empirically-validated 
treatment options should be considered.  
Despite the prevalence of substance use disorder and high relapse rates among 
adolescents and young adults, there has been a lack of research on the effectiveness of 
adjunctive therapies for this population. 5  Most patients in this age group are provided 
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similar treatment as adults, or to treatments that do not address the concerns listed 
above. Additionally, research shows that substance use disorders are more likely to be 
lifetime disorders than anxiety or depression in young adults. 6 Considering this, it is 
imperative that there be more research to assist in preventing the likelihood of the substance 
use disorder from becoming a life-long issue for young adults.   
As mentioned previously, there are many necessary considerations for adolescents and 
young adults seeking treatment for substance use disorder.  The most prominent of these 
include stigma, cost, and accessibility. 2,3 While considering these factors, there are few 
standard treatments offered to these patients that address all of them.  Many of these 
patients will experience stigma for seeking help, as well a lack financial means and 
transportation. Therefore, new treatment options should be considered that will address 
these concerns. 2 
 
1.1.2 Potential for Technology-Based Treatments for adolescents and young adults with 
SUD 
There has been a prominent rise in the use of technology and computer-based activities 
in young adults and adolescents. 7 A review by Marsch et al., found that not only are over 
74% of young adults using social media platforms daily, but almost 87% of Americans 
are subscribed to a cell-phone plan with internet access. 7 In addition, the rate of increase 
in the use of mobile devices to access the Internet among minority groups is twice the 
national average since 2007; for example, there was a 141% increase in use among 
African Americans versus the 73% average increase. 7 These statics show the relevancy 
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of utilizing technology to deliver treatment methods as being accessible for all people, 
including minorities. Therefore, utilizing technology for treatments is an effective 
solution to address the aforementioned barriers to care.  
Not only would technology help eliminate the barrier of access to treatment, but also 
stigmatization and cost. 8-10 A study by Olmos et al., compared technology-based 
treatment to TAU for participants looking to decrease their cannabis use. The study found 
that there was a lower incidence of cannabis use in patients utilizing technology rather 
than TAU. 8 Reasons cited for this include a reduction in stigmatization by delivering 
therapy online, without an in-person therapist, and a lower cost for treatment and 
transportation. 8  Additionally, while there is a clear increase in interest for this form of 
intervention, younger generations are more prepared to make this adaptation. A study by 
Antoine et al., sought to differentiate the interest in these technology-based treatments by 
age group and found a positive correlation between interest in technology-based 
treatment and younger ages. 5  
In addition to a rise in technology use, there has also been a rise in interest and research 
about technology-based interventions for substance use disorders. 2 Many researchers 
have sought to adapt treatment options for this new generation of technology users. 
Recent research reported that there is a  place for treatment for SUD via smart 
technology. 11 Additionally, it was found that participants even preferred using their 
smartphone for treatment (46.8%), rather than being in person (36.2%). 11 This clearly 
supports that technology-based interventions have risen in popularity. These interventions 
have the potential to provide valuable assistance those who have substance use 
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disorders.12,13 For example, current technology based interventions have improved 
adherence management, reinforced evidence-based psychosocial interventions, improved 
communication between patient and physician, increased the retention in office-based 
treatment, and increased abstinence with minimal disruption to health care personnel and 
clinical workflow. 2,9 
1.1.3 Utilizing CBT4CBT for adolescents and young adults with SUD 
One of the new prominent forms of treatment for substance use disorders is CBT4CBT, 
or Computer Based Therapy for Cognitive Behavioral Therapy.  This program introduces 
cognitive and behavioral skills to assist patients in gaining control of their substance use 
disorder and is relatively low-cost per patient compared to in-person interventions. 27 
This program is a web-based interactive guide that includes seven different core skills 
that can be completed at the user’s individual pace. 1,14,15  These skills/lessons include on-
screen narration, video-based vignettes, quizzes, interactive exercise, and graphic 
animation to teach effective use of skills. 16  After completion of each lesson, there are 
take home practice exercises (i.e., homework) to further enhance the skills taught through 
cognitive behavioral therapy. 16  It is also user-friendly, with little to no previous 
experience on computers required and includes minimal reading. 17  The modules within 
the program are based on the Cognitive Behavioral Therapy manual published by NIDA, 
which is considered an evidence-based intervention for treating substance use disorders. 
17  With these aspects of the treatment in mind, CBT4CBT can address many of the needs 
for young adults initiating treatment for a substance use disorder as it is affordable, user 
friendly, and accessible for everyone that can access a computer.  
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The efficacy of computer-based cognitive behavioral therapy has been consistently 
demonstrated through several randomized clinical trials. These trials found that when 
CBT4CBT was provided in addition to treatment as usual (TAU, standardized treatment 
including weekly group and/or individual therapy, and pharmacotherapy ), the self-
reported days of abstinence from participants’ most commonly used drug was 
significantly increased, when compared to TAU as the primary treatment regimen. 14 
These same treatment conditions were compared in another trial with  patients enrolled in 
methadone maintenance who were currently also cocaine dependent.  The study found 
that individuals assigned to CBT4CBT with TAU were significantly more likely to attain 
at least 3 weeks of continuous abstinence from cocaine compared to those who only 
received TAU. 1, 8  Additionally, not only is CBT4CBT effective in increasing abstinence 
in the short-term, it is also durable in its effects. A study of follow-up data from the initial 
trial in 2008 showed that participants receiving CBT4CBT maintained the gains they had 
achieved in treatment up to 6-months after treatment termination, while those assigned to 
TAU tended to return to their patterns of drug use. 15  Furthermore, participants assigned 
to CBT4CBT rather than TAU were significantly more likely to submit a drug-negative 
urine specimen during follow up. 15  
This novel treatment represents advancements in the field of substance use disorders 
that should be used more widely in adolescents and young adults suffering from 
substance use disorder.19 CBT4CBT can provide young adults and adolescents with 
substance use disorders an evidence-based, high-quality form of treatment.20  Therefore, 
this study would generate comparative data between TAU and TAU plus CBT4CBT in 
hopes of providing this population of young adults and adolescents with another form of 
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low-cost treatment that is more effective, while also allowing for privacy and 
accessibility. 21 
1.2 Statement of the Problem 
Young adults and adolescents face high barriers to treatment for SUDs such as cost, 
accessibility and stigma. 4 Not only does this population face these difficulties in 
initiating treatment, they also face high relapse rates if they do go through with treatment. 
4  One of the most well validated and effective treatments for SUD in young adults and 
adolescents is cognitive behavioral therapy. 22,23 However, this age group is unlikely to 
proceed with this treatment as it is expensive and often inaccessible. 8,9 There have been a 
number of studies using CBT4CBT as a low cost and accessible adjunctive intervention 
for people with SUD.1,15,16,18,20,24 However, none of these studies have validated this 
treatment for young adults and adolescents. Therefore, we propose a randomized 
controlled trial (RCT) to evaluate the efficacy of CBT4CBT as an adjunctive treatment to 
TAU in adolescents and young adults with SUDs. The results gained by this novel study 
have the potential to provide a low-barrier option for effective treatment for young adults 
and adolescents with SUD. 
1.3 Goals and Objectives 
The overall objective of this study is to provide an efficacious and validated 
adjunctive treatment for adolescents and young adults with substance use disorders. This 
RCT will compare a TAU control group to TAU plus CBT4CBT intervention group to 
examine if there is a significant difference in the percentage of negative urine toxicology 
screens during an 8-week treatment, and up to 6 months after the completion of 
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treatment. Treatment as usual (TAU) will consist of the typical treatment recommended 
for this age group in an outpatient setting. This will include but is not limited to: 
psychotherapy, group therapy, medications. CBT4CBT is a seven-session online program 
that can be completed over a period of 8 weeks, on any smart device.  
The primary outcome will be the percentage of drug-negative urine samples. Once 
participants initiate treatment, they will be asked to submit urine samples weekly for the 
eight weeks of treatment when they are at the clinic for their TAU. We will continue to 
collect urine at one, three, and six months after the conclusion of the eight-week study as 
a secondary outcome. Other secondary outcomes for our analysis will assess the 
percentage of days during treatment that participants self-report using drugs, or frequency 
of drug use. This outcome will be assessed through self- report, utilizing the Time Line 
Follow Back (TLFB) method. The TLFB assessment will be administered at the same 
time as every urine specimen is given, as the urine specimen will be used validate the 
self- report.  Additional secondary outcomes include mental health and severity of 
substance use measures from the Patient Reported Outcomes Measurement Information 
System (PROMIS). This is a set of validated measures, that will provide the ability to 
evaluate aspects of mental and social health as well as addictive behaviors in young 
adults and adolescents. 25,26The results of this study will determine the efficacy of 
CBT4CBT as a low barrier adjunctive treatment option for adolescents and young adults 
with SUDs. Finally, we will examine the engagement in treatment as measured by the 





Among adolescents and young adults (13-24) with a newly diagnosed substance use 
disorder, those receiving weekly Computer Based Therapy for Cognitive Behavioral 
Therapy (CBT4CBT) plus the standard treatment will have a statistically significant 
higher percentage of drug-negative urine toxicology screens collected during the eight 
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We conducted an extensive and thorough review of the literature between 
November 2020-June 2021 using Pubmed, Ovid (Medline), PSYCinfo, Web of Science 
and Cochrane Review. Only articles in English were read. An initial review of each 
article utilizing their title and abstract was used to determine the relevance of each study. 
Key terms used in every databased to find articles that relate to our study population and 
intervention were: substance use disorder, substance abuse, drug abuse, drug 
dependence as well as adolescents, young adults, and the age group of 13-24 and 
cognitive behavioral therapy. Terms used to identify overlap between the study setting 
and intervention were: cognitive behavioral therapy, behavioral treatment, CBT, 
computer based, computer delivered, technology delivered and computer assisted. Terms 
used to identify the model CBT4CBT intervention include: CBT4CBT, Computer Based 
Training for Cognitive Behavioral Therapy, and computer-assisted cognitive behavioral 
therapy.  
2.2 Review of Empirical Studies 
 
2.2.1 CBT4CBT as an Intervention for Substance Use Disorder 
 
 Computer-based interventions are an effective and feasible form of treatment for 
substance use disorder. 1  In a meta-analysis by Riper et al., it was reported that of sixteen 
studies, internet interventions for treatment of alcohol use showed a statistically 
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significant effect (p = .056) in reducing alcohol consumption over standardized treatment 
such as in-person group therapy or psychotherapy. 2  While there is not yet a review 
comparing all computerized behavioral interventions for SUD, this meta-analysis 
supports the efficacy of computer-based therapies that can be low cost compared to 
standard treatments. 2,3  In a recent systematic review, the authors found that multiple 
forms of computer assisted behavioral therapy also had a statistically significant effect on 
decreased use of opioids, when compared to TAU (treatment as usual). 4  In the context 
of treating SUD, cognitive behavioral therapy has also proven to be incredibly efficacious 
in both adult and adolescent populations. 3,5,6 A relevant randomized controlled trial by 
Dennis et al., reported that in a population of 600 adolescent subjects with alcohol use 
problems randomized to 5 different intervention groups, the interventions that included 
CBT were the most efficacious in increasing total days of abstinence, as well as the 
highest percentage of subjects in recovery. 7  
 CBT has been one of the most researched and evaluated behavioral therapies for 
SUD with considerable empirical support demonstrating its efficacy at reducing alcohol 
and drug use.3,4,6,8,9   Computer/technology-delivered interventions have emerged in the 
past decade as promising platforms for delivering evidence-based treatments, including 
CBT.  One such computer-delivered CBT program is CBT4CBT. 1 A pilot study of the 
program CBT4CBT by Carroll et al., randomized 77 individuals seeking treatment for 
substance dependence to either TAU or TAU and CBT4CBT for an eight-week period. 1 
The CBT4CBT intervention uses module-based computer lessons to engage participants 
in a user- friendly and palatable way. The goal of this strategy is to provide a 
standardized and accessible form of cognitive behavioral therapy. 1 This study found that 
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those randomized to CBT4CBT plus TAU submitted 19% fewer urine specimens positive 
for any drug (p=0.5), and had a 5 day longer period of abstinence than those receiving 
TAU only. 1  Additionally, subjects were also followed for 6 months to examine the 
durability of their treatment. The results of this showed that those assigned to CBT4CBT 
submitted fewer positive drug urine specimens (48% vs 76% of control group) and had an 
average of 105 consecutive days abstinent, compared to 72.5 days abstinent in the control 
group (p=0.5).  10 This outcome was statistically significant. 10  Not only was CBT4CBT 
more effective during the eight-week treatment period, it was also successful in its 
durability over the control.  It is important to note however, that 34% of subjects did not 
complete the study in both intervention and control groups. Therefore, this is the most 
likely reason that analysis of the one of the primary outcomes for this study (frequency of 
substance use) was not statistically significant. This study highlights the need for a larger 
sample size, of large subgroups of participants, as well as utilizing CBT4CBT as a 
promising treatment. 1 
This pilot study, as well as a second study that extended the efficacy findings to a 
methadone-maintained sample, examined CBT4CBT as an add-on to standard outpatient 
treatment. 11  Subsequent trials were conducted to evaluate CBT4CBT as a potential 
stand-alone treatment compared to in-person counseling.  In a RCT by Kiluk et al., 137 
individuals with substance use disorder were recruited to evaluate the efficacy of 
CBT4CBT provided with brief clinical management compared to treatment as usual 
(TAU).  This trial also included a clinician-delivered CBT condition, although the 
computerized and clinician-delivered CBT conditions were not directly compared. 
Participants were randomized to TAU, CBT4CBT or clinician CBT. The primary 
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outcome of this study was the frequency of substance use over the 12-week treatment 
period. 12  Clinician CBT was delivered via a PhD with standardized training in CBT. 
Participants were assessed before treatment, weekly during treatment, at the 12-week 
treatment termination point, and 1, 3, and 6 months after the termination point. 12 The 
results of the study showed that participants assigned to either clinician CBT or 
CBT4CBT had greater reductions in drug and alcohol use during the treatment period as 
compared to TAU.  Also, those assigned to either CBT condition were less likely to meet 
DSM5 criteria for a substance use disorder by the end of treatment as compared to TAU.  
Further, those assigned to CBT4CBT showed sustained reductions in substance use 
during the 6-month follow-up period compared to TAU.    
 There has been a total of 8 RCTs evaluating CBT4CBT in different settings and 
populations, all demonstrating the efficacy of CBT4CBT at reducing rates of substance 
use.  Clearly, this is an evidence-based intervention with multiple benefits.  As is true for 
nearly all computer or technology-delivered interventions, CBT4CBT removes traditional 
barriers to evidence-based and affordable care to all patients. All CBT4CBT studies have 
utilized patient populations that need accessible and affordable care.1,10,12 Also, by using 
the same standardized computer program for every patient utilizing CBT4CBT, treatment 
equity is ensured.  This virtually eliminates concerns regarding variability in the quality 
of clinician-delivered care. 1 These components of CBT4CBT demonstrate the need for a 
program like this in all communities facing issues with substance use disorder, by 




Figure 1: The Seven Lessons of CBT4CBT 35 
 
2.2.2 CBT for Adolescents and Young Adults with Substance Use Disorder 
 
CBT4CBT has shown success in the majority of populations facing issues with 
SUD. However, one key group missing in these studies is young adults and adolescents. 
Using CBT4CBT as a primary intervention for our population would be a revolutionary 
form of treatment for people age 13-24 in need of affordable access to treatment. While 
there are no studies evaluating the use of CBT4CBT on young adults and adolescents, 
there are a number of studies assessing the use of CBT in this population for SUD, as 
well as internet-based therapies.  
In a retrospective analysis, Davis et al., included 785 adolescents age (12-17) and 
young adults (ages 18-29) entering treatment for opioid use disorder from over 137 sites.  
Participants were either assigned to TAU, MET/CBT or adolescent community 
reinforcement approach (A-CRA). 13 The primary outcome of this study was days to first 
relapse or use of an opioid, assessed by self-reported substance use. The results 
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concluded that female youth in the A-CRA intervention experienced an episode of 
substance use 12 days sooner than those in TAU and MET/CBT, and that in male youth, 
those receiving MET/ CBT took one month longer to return to opioid use. The study also 
compared the ages at which CBT was most useful and determined that the older the 
participant, the less effective CBT was. 13 While this study is important in demonstrating 
the feasibility of using CBT in our population for treatment of SUD, it did have 
limitations in that there was no evaluation of computer delivered CBT, which may have 
enhanced the efficacy. Additionally, there was no confirmation of self-reported opioid 
use with urinalysis.  
Similarly, in a systematic review of 188 studies by Steel et al., adolescents between the 
ages of 12 and 20 with substance use disorders, not including tobacco were included. All 
forms of treatments including pharmacologic and behavioral were included in the review. 
In terms of behavioral therapies, the authors found that “adolescents who received CBT 
and education were about 3 times more likely to be abstinent at 1 year than those who 
received education alone (16% vs. 5%; RR 3.20, 95% CI 1.34 to 7.65).” 14 This analysis 
is yet another important study to justify the use of CBT in adolescents. It does not 
however address the potential use of computerized delivery of any form of behavioral 
intervention. 
One study that exemplifies the effectiveness of CBT for adolescents in SUD is a RCT 
by Ogel et al., conducted in Turkey, 62 males were recruited from a hospital setting for 
either “volatile substance dependence” (deliberate inhalation of volatile substances in 
order to achieve intoxication) or “polysubstance dependence” according to DSM-IV-TR 
criteria.15 The subjects in the study were placed either in a CBT based intervention or 
17 
 
educational program that educated them on the harmful effects of drug use. The subjects 
were followed for one year after treatment for self-reporting of substance use. The results 
of the study showed that despite a larger percentage of the experimental group dropping 
out (20% difference), the group assigned to CBT had a statistically significant lower rate 
of relapse compared to the control. 15 There were however factors of this study that differ 
significantly from ours. First, there is no use of the computer assisted technology, 
ensuring standardized treatment. Second, the primary outcome relied on self-report rather 
than urinalysis. 15 Finally, while this study did utilize a population of subjects with 
substance use disorder, they were also associated with volatile substance use rather than 
solely SUD. 15 The study currently proposed will not be tested on subjects that have 
volatile substance dependence.  
A specific study that highlights the superiority of CBT as treatment for adolescents 
with SUD over age specific treatments was performed by Dennis et al,.7 This was a 
double randomized control trial that studied 600 adolescents and their families that were 
all recruited and randomized from sequential admissions to four treatment sites within 
CT. The subjects of this study were all diagnosed with a substance use disorder as well as 
a co-occurring psychiatric disorder. 7 There were 2 different trials within the study. The 
first trial randomized participants to either five sessions of Motivational Enhancement 
Therapy plus Cognitive Behavioral Therapy (MET/CB5T) or twelve sessions of MET 
and CBT (MET/CBT12) or another group that included family education and therapy 
components (Family Support Network [FSN]). The second trial randomized the subjects 
to either a five-session MET/CBT or the Adolescent Community Reinforcement 
Approach (ACRA) or Multidimensional Family Therapy (MDFT). 7 The primary 
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outcomes of the study were days of abstinence between the randomization date and the 
12-month follow up interview as well as if the adolescent was in recovery at the end of 
the study. Overall, the study showed that in the first trial, the percent in recovery at the 
end of the study was 27% in the CBT group, 22% in the FSN group. The same primary 
outcome of the second trial was not statistically significant. 7 Similar to other trials, this 
trial lacked in its use of computer-based CBT. Additionally, it did not use urinalysis to 
confirm self-reporting of abstinence.  
While it is well established that CBT in youths is efficacious in treating SUD, there are 
much fewer trials regarding computer-based CBT. One study that did address this was 
performed by Braciszewskia et al. This RCT recruited 18–19-year-olds with substance 
use disorders that were leaving foster homes. The participants were randomized 
to Interactive Healthy Lifestyle Preparation (Ihelp), a technology-based substance use 
intervention that utilizes motivational interviewing. 16 The primary outcome was 
percentage of days without substance use over a 6-month treatment period. The outcome 
of the study showed that participants preferred the ease of online treatment. Additionally, 
the intervention group also had a statistically significant higher percentage of days 
abstinent than the control which entailed a different computer program that focused on 
diet. 16  This study showed the feasibililty of online treatment for adolescents. It differs 
from ours however as the population is different with only 18-19 year-olds exiting foster 
care. Moreover, the primary treatment includes motivational interviewing which has been 
found to be inferior in adolescents compared to CBT. 4 
Ebert et al., in 2015 conducted a meta-analysis of studies evaluating computer-based 
CBT interventions for adolescents with a diagnosis of anxiety and depression. 17 The 
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study included 796 participants that were treated for their anxiety or depression with an 
internet or computer based cognitive behavioral treatment.  Results from the meta-
analysis showed that there was a statistically significant improvement in the adolescents’ 
anxiety and/ or depression. The authors concluded that computer-based CBT would be a 
useful treatment for adolescents, particularly in those where there may be limitations to 
face-to-face treatment. 17  This study is a prime example of why computer based 
cognitive behavioral therapy should also be examined in adolescents with substance use 
disorder.  
Of the few studies reported utilizing computer-based therapies or cognitive behavior 
therapy for adolescents and young adults with substance use disorder there is a general 
theme of providing accessible and quality care to patients. 13-17 All of the studies aim to 
increase the accessibility by providing low barrier and evidence-based care. They help 
demonstrate the feasibility of implementing CBT4CBT for young adults and adolescents 
with substance use disorder as an effective and accessible treatment.  While there are 
limited studies that directly focused on utilizing computer based cognitive behavioral 
treatment for adolescents and young adults with substance use disorders, the current data 
demonstrates that CBT4CBT is a well-studied accessible treatment that can be applicable 
to adolescents with substance use disorder. This literature review found statistically 
significant evidence that young adults and adolescents can respond well to computer-
based therapies, and that CBT4CBT is an effective adjunctive therapy. The proposed 
project will extend the evaluation of CBT4CBT to young adults and adolescents with 




2.3 Identifying confounding variables 
 
While reviewing the related literature, we identified several confounding variables that 
will be addressed in our study design. First, age group has been found to be a moderating 
variable in the effectiveness of CBT. 13 Thus, we will use stratified random sampling to 
randomize participants by their age group, either young adults or adolescents. The age cut 
offs being 13-17 for adolescents and 18-24 for young adults. By using stratification based 
on age group, we’ll ensure equal distribution of each age group among the treatment and 
control groups. 
A previous study on treatment retention for substance use disorders sought to identify 
if there was a difference in treatment retention based on type of substance use (alcohol or 
drugs, or alcohol and drugs) as well as race and gender. 18  It was found that all of these 
factors have the capability to impact the treatment retention. Given these findings, we 
will consider these demographic as confounders and measure them at baseline to ensure 
comparability across both groups.  
Additionally, personal demographics and environmental factors have been found to 
correlate with success of treatment for youths with substance use disorder. Factors 
acknowledged in a study by Anderson et al,. include age, sex, race, socioeconomic status, 
diagnosis of type of SUD, and substance use characteristics such as episodes per month 
of substance use. 19 All of these factors have the potential to impact the patient’s 
likelihood of relapse. Therefore, we will assess these characteristics at baseline. If there 
are any imbalances between intervention and control groups then it will be adjusted for 
with statistical analyses via analysis of covariance (ANCOVA).  
21 
 
Other similar RCTS on CBT4CBT have assessed whether randomization was 
successful and to identify confounders. They compared the intervention and control arms 
of the study to identify confounders based on baseline characteristics of subjects in each 
arm.1,20  Examples of the characteristics in these studies include: severity of addiction, 
comorbid conditions, mental illness, age, education level and sex/ gender. These will also 
be assessed in our study to ensure the treatment conditions are balanced with respect to 
these characteristics. 
  
2.4 Review of relevant methodology 
 
 2.4.1 Study Setting and Design 
 
We will conduct a multi-site study which will include participants from primary care 
clinics within the New Haven County area. The proposed study has a multi-center design 
to expand our generalizability of aforenoted variables as well as to ensure adequate 
recruitment to reach statistical significance.  According to the Department of Public 
Health surveillance data, New Haven county consistently has one of the highest monthly 
numbers for ED visits for suspected drug overdoses of adolescents and adults within 
Connecticut. 21 This data is suggestive of the high levels of substance use disorder within 
New Haven county, ensuring that this area will have enough participants that meet the 
inclusion and exclusion criteria for our study.  CBT4CBT is utilized as an accessible, 
affordable, and effective treatment platform. 5 Therefore, this particular county, having 
one of the lowest socio-economic statuses in CT would benefit greatly from the program.  
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Our study will target adolescents and young adults age 13-24 with substance use 
disorder and randomly assign them to either CBT4CBT + TAU, or TAU alone. 
CBT4CBT contains 7 modules (i.e., core topics) that was modeled after the NIDA 
published manual for CBT. 1 Each module covers one of the core concepts of CBT. They 
include: understanding and changing patterns of substance use, coping with craving, 
refusing offers of drugs and alcohol, problem-solving skills, identifying and changing 
thoughts about drugs and alcohol, and improving decision-making skills. 1 The modules 
use engaging videos and questions to help the participant navigate through risky 
situations. The goal is to enable the user to navigate through tough situations without 
resorting to substance use. 11 The program can be accessed from any device with internet 
access (e.g., smartphone, tablet, laptop, desktop), which will be a requirement to 
participate in this study.  
 
 2.4.2 Review of Recruitment Techniques 
 
This study will recruit individuals from the primary care clinics within the New Haven 
County area. The recruitment technique we will be using in this study will be the referral 
approach. This approach involves having colleagues of the recruitment site giving 
information to potential participants about this study.  More specifically, we will be using 
the chain referral method. This method is most effective for hard-to-reach, sensitive 
populations such as young adults and adolescents with SUD. 22  Chain referral has a 
seven-step method of sampling:  
1. Defining the population and subjects 
2. Considering the sample size. 
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3. Selecting and assessing settings.  
4. Gaining access. 
5. Initiating chains and identifying locators. 
6. Pacing and monitoring of the referral chains. 
7. Discontinuing the referral chains. 22 
Utilizing these steps, we will be able to tap into the hard-to-reach population, and 
access a greater number of subjects than if we were to rely on physician referral. This 
effectively works by identifying a small set of subjects, who will then be asked to help 
identify and recruit more subjects. 22 This will be monitored extensively to ensure 
diversity and proper inclusion/ exclusion criteria.  Strengths of this approach include 
gaining access to a diverse population, while maintaining privacy of the participants.   
 
 2.4.3 Inclusion and exclusion criteria 
 
Inclusion and exclusion criteria will be similar to those from RCTs involving 
CBT4CBT and CBT for adolescents and young adults. Our inclusion criteria will be most 
closely modeled after a study by Tetrault et al., that evaluated CBT4CBT in adults with 
SUD diagnosed by primary care physicians as well as a trial by Sweeney et al., that 
studied adolescents with substance use disorder. Inclusion criteria will include: fluency in 
English, ability to read at 6th grade level, be willing to engage in treatment and meet the 
current DSM 5 criteria for substance use disorder, access to a smart device with internet 
access, and ages 13-24. 23,24 The exclusion criteria will include: any untreated psychotic 
disorder, current legal case pending where incarceration is possible, any condition 
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requiring hospitalization, active drug withdrawal, current engagement in treatment for 
SUD, or any condition with significant cognitive impairment.  23,24 
 
 2.4.5 Review of successful CBT4CBT components- The Intervention 
 
There have been multiple RCTs of CBT4CBT.  CBT4CBT has been shown to be an 
effective and enduring treatment for substance use disorder. 3,25 According to multiple 
recent trials, not only was it effective, it also had the highest rate of adherence and 
participant satisfaction compared to standard treatment. 1,11,26 With this in mind, our 
proposed study will utilize CBT4CBT in a population that typically has low access to 
care, and high rates of relapse. 27 
 
2.4.6 Review of the Primary Intervention: CBT4CBT 
  
The core components of CBT4CBT includes 7 core modules that teach cognitive as 
well as behavioral skills. The skills teach the user tactics to help them gain control over 
their use of drugs or alcohol. 28 These skills include: recognizing and changing patterns of 
use, coping with craving and urges to use drugs or drink, challenging and changing 
negative thoughts, improving decision making skills, learning how to say no effectively, 
and improving problem-solving skills. 28   
The modules take approximately thirty minutes to complete and can be completed at 
the person’s individual pace. They utilize video-based instruction and interactive games 
to engage the user. 28 The modules are structured to keep engagement throughout the 
thirty minutes as well. Initially, the user watches a short movie that uses actors in a 
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realistic setting that display a high-risk situation for substance use. There is then a 
narration over the movie, explaining what went wrong in the situation and how to change 
the outcome to avoid substance use. The movie then replays with this new outcome. 29 
There are additional interactive vignettes to show how they use this skill in different 
ways. 29 After the videos, there is a short quiz and vignette to help solidify to the user the 
cognitive behavioral training skills that were taught in this module. There are also 
explanations of how this skill could be use in different settings. This also helps to address 
common areas of resistance in CBT. 29 The end of the module consists of a narrator 
reviewing the key skills they learned as well as example of how the user can complete 
their homework for the week, to practice the skills they learned within the module. 29 
The average user will take about 8 weeks to complete the entire CBT4CBT program. In 
all prior studies of CBT4CBT a research assistant has been available to assist the user in 
accessing the program and guiding them through the initial login, as well as answer 
questions as needed. 30  Our study will also utilize this method in assisting participants, 
however research assistant may be available over the internet rather than in person for 
assistance. 
 
2.4.7 Content of Control Condition 
 
Our control condition, otherwise known as “treatment as usual” or TAU, will be the 
typical outpatient treatment a participant would receive for their substance use disorder.  
The standard treatment will depend on the site the patient is at. 31 However, it typically 
will consist of individual or group counseling for their substance use disorder. 
Participants assigned to TAU will engage in these sessions for 8 weeks. 31  
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With review of the aforementioned studies as well, in addition to other similar studies, 
1,10,29 TAU will involve individual or group therapy, as well as any other services by the 
participant needed (e.g., ancillary psychiatric services, case management), and very close 




The primary outcome for our study is the percentage of urine samples that are negative 
for substances during the 8-week treatment. This has been assessed in previous studies 
through periodic assessments during the study, as well as after the study treatment period. 
In all prior studies of CBT4CBT participants were screened via urinalysis prior to the 
initiation of treatment, as well as weekly during treatment period and at the conclusion of 
treatment. 1  
As a secondary outcome to evaluate enduring effects of CBT4CBT, participants have 
been screened via urinalysis at 1-, 3- and 6-month intervals post treatment. 10  We will 
adapt this model of urine screening up to 6 months post treatment to track the progress of 
the participants after treatment. Once participants initiate treatment, they will be asked to 
submit urine samples when they are at the clinic for their weekly TAU, as well as asked 
to come back to submit urine samples after treatment. The test will be administered and 
supervised by a clinician or research assistant. Additionally, we will examine the 
engagement in treatment as measured by the number of SUD treatment sessions attended 
and/or CBT4CBT modules completed. 
Secondary outcomes for our analysis will assess the percentage of days during 
treatment that the participant uses drugs, or frequency of drug use. This outcome will be 
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assessed through self- report, utilizing the Timeline Follow Back (TLFB) method as 
recommended by Levy et al. 32 The study performed by Levy et al., tested the reliability 
of adolescents (12-18 years old) self-reporting drug use with the CRAFFT screen vs 
TLFB. It was determined that the TLFB is a reliable method of self- reporting for 
adolescents when reporting their current usage of substances. 32 The TLFB will be 
administered at the same time as every urine specimen is given, as the urine specimen 
will validate the self- report. 10 
Additional secondary outcomes include instruments measuring mental health and 
severity of substance use from the Patient Reported Outcomes Measurement Information 
System (PROMIS). 33,34 We will utilize three of these measures: Emotional and 
Behavioral Dyscontrol, Self-Efficacy, and Severity of Substance Use. The survey for 
Emotional and Behavioral Dyscontrol is a self-report of behavioral and emotional 
experiences over the past 7 days, and will be administered weekly along with the TLFB. 
Both the Self-Efficacy and Severity of Substance Use questionnaires measure items over 
the past 30 days and will be administered at the beginning of the study and the end of 
treatment. Results from all three surveys will be scored and evaluated by a research 
technician.  
 
2.4.9 Review of Sample Size and Calculation Power 
 
Our sample size calculation was determined primarily by the results of Carroll et al., 
with additionally considerations from Sweeney et al.  In Carroll et al.’s original study on 
CBT4CBT, they found that participants being treated with CBT4CBT submitted 34% of 
their total urine specimens positive for substances within the time of treatment and the 
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subjects in the control group had a result of 53% of their total urine specimens positive 
for substances during the treatment time. 1 This results in a cohen’s d effect size of 0.46, 
which we will use for our study as this effect size is of the same outcome. 
A study by Sweeney et al., analyzed using working memory training (a computer based 
cognitive training) for adolescents with cannabis use disorders. 24 One of the outcomes of 
this study was, urinalysis similar to our primary outcome. Subjects were asked to submit 
urine specimens weekly for the duration of their treatment. The study found that at the 
conclusion of treatment, the intervention arm had a 40% probability of submitting a 
positive urine sample, and the control arm had about a 60% probability of submitting a 
positive urine sample. 24 With an effect size of approximately 20%, we determined that 
this adolescent population was comparable to the population we will be basing our 
sample size off in Carroll et al.’s study. 10 
Ultimately, a prospective, randomized clinical trial study found that the association 
between relapse rates and CBT4CBT treatments to be significant, where participants 
being treated with CBT4CBT submitted 34% of their total urine specimens positive for 
substances within the time of treatment and the subjects in the control group had a result 
of 53% of their total urine specimens positive for substances during the treatment time. 1 
Using this cohen’s d effect size of 0.46, a 2-sided significance level of 0.05, and an 80% 
power, we calculated a minimum sample size of 150.      
     
2.5 Conclusion 
 
While CBT4CBT has been shown to be efficacious at reducing substance use and 
durable throughout this literature review across various populations, this form of 
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treatment has yet to been tested in the younger population. It is even more important 
knowing that young adults and adolescents having high rates of relapse, 27 and having 
similar numbers of emergency department visits per month for substance use overdose 
compared to the adult population within New Haven county.  21  The information 
suggests CBT4CBT may be a promising intervention for substance use disorder in the 
adolescent and young adult population. Our study design utilizes the original methods 
used to test CBT4CBT while incorporating aspects to ensure this study will be applicable 
to a new population. Through our literature review, we have described the aspects of our 
study design as well as the different aspects of the previous research that states the need 
for this intervention. Our study will add to the literature a new intervention for young 




1. Carroll KM, Ball SA, Martino S, et al. Computer-assisted delivery of cognitive-
behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J 
Psychiatry. 2008;165(7):881-888. 
2. Riper H, Blankers M, Hadiwijaya H, et al. Effectiveness of guided and unguided 
low-intensity internet interventions for adult alcohol misuse: a meta-analysis. 
PLoS One. 2014;9(6):e99912. 
3. Kiluk BD. Computerized Cognitive Behavioral Therapy for Substance Use 
Disorders: A Summary of the Evidence and Potential Mechanisms of Behavior 
Change. Perspect Behav Sci. 2019;42(3):465-478. 
4. Boumparis N, Karyotaki E, Schaub MP, Cuijpers P, Riper H. Internet 
interventions for adult illicit substance users: a meta-analysis. Addiction. 
2017;112(9):1521-1532. 
5. Kiluk BD, Carroll KM. New Developments in Behavioral Treatments for 
Substance Use Disorders. Current Psychiatry Reports. 2013;15(12):9. 
6. Magill M, Ray L, Kiluk B, et al. A meta-analysis of cognitive-behavioral therapy 
for alcohol or other drug use disorders: Treatment efficacy by contrast condition. 
J Consult Clin Psychol. 2019;87(12):1093-1105. 
30 
 
7. Dennis M, Godley SH, Diamond G, et al. The Cannabis Youth Treatment (CYT) 
Study: main findings from two randomized trials. J Subst Abuse Treat. 
2004;27(3):197-213. 
8. Fonagy ARaP. What Works for Whom? Second Edition A Critical Review of 
Psychotherapy Research. New York: The Guilford Press; 2005. 
9. Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 
2005;162(8):1452-1460. 
10. Carroll KM, Ball SA, Martino S, Nich C, Babuscio TA, Rounsaville BJ. Enduring 
effects of a computer-assisted training program for cognitive behavioral therapy: a 
6-month follow-up of CBT4CBT. Drug Alcohol Depend. 2009;100(1-2):178-181. 
11. Carroll KM, Kiluk BD, Nich C, et al. Computer-assisted delivery of cognitive-
behavioral therapy: efficacy and durability of CBT4CBT among cocaine-
dependent individuals maintained on methadone. Am J Psychiatry. 
2014;171(4):436-444. 
12. Kiluk BD, Nich C, Buck MB, et al. Randomized Clinical Trial of Computerized 
and Clinician-Delivered CBT in Comparison With Standard Outpatient Treatment 
for Substance Use Disorders: Primary Within-Treatment and Follow-Up 
Outcomes. Am J Psychiatry. 2018;175(9):853-863. 
13. Davis JP, Prindle JJ, Eddie D, Pedersen ER, Dumas TM, Christie NC. Addressing 
the Opioid Epidemic With Behavioral Interventions for Adolescents and Young 
Adults: A Quasi-Experimental Design. Journal of Consulting & Clinical 
Psychology. 2019;87(10):941-951. 
14. Steele DW, Becker SJ, Danko KJ, et al. Agency for Healthcare Research and 
Quality. 2020:05. 
15. Ögel K, Coskun S. Cognitive behavioral therapy-based brief intervention for 
volatile substance misusers during adolescence: a follow-up study. Subst Use 
Misuse. 2011;46 Suppl 1:128-133. 
16. Braciszewski JM, Tzilos Wernette GK, Moore RS, Bock BC, Stout RL, 
Chamberlain P. A pilot randomized controlled trial of a technology-based 
substance use intervention for youth exiting foster care. Children and Youth 
Services Review. 2018;94:466-476. 
17. Ebert DD, Zarski AC, Christensen H, et al. Internet and computer-based cognitive 
behavioral therapy for anxiety and depression in youth: a meta-analysis of 
randomized controlled outcome trials. PLoS One. 2015;10(3):e0119895. 
18. McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: 
patient versus substance use characteristics. Drug Alcohol Depend. 2001;62(1):9-
17. 
19. Anderson KG, Ramo DE, Schulte MT, Cummins K, Brown SA. Substance use 
treatment outcomes for youth: integrating personal and environmental predictors. 
Drug Alcohol Depend. 2007;88(1):42-48. 
31 
 
20. Campbell ANC, Nunes EV, Pavlicova M, et al. Gender-based Outcomes and 
Acceptability of a Computer-assisted Psychosocial Intervention for Substance Use 
Disorders. Journal of Substance Abuse Treatment. 2015;53:9-15. 
21. Health DoP. DPH Releases New Data on Numbers of Suspected Drug Overdoses 
Seen in CT Emergency Rooms 2018. 
22. Penrod J, Preston DB, Cain RE, Starks MT. A discussion of chain referral as a 
method of sampling hard-to-reach populations. J Transcult Nurs. 2003;14(2):100-
107. 
23. Kiluk BD, Devore KA, Buck MB, et al. Randomized Trial of Computerized 
Cognitive Behavioral Therapy for Alcohol Use Disorders: Efficacy as a Virtual 
Stand-Alone and Treatment Add-On Compared with Standard Outpatient 
Treatment. Alcohol Clin Exp Res. 2016;40(9):1991-2000. 
24. Sweeney MM, Rass O, DiClemente C, et al. Working Memory Training for 
Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial. J 
Child Adolesc Subst Abuse. 2018;27(4):211-226. 
25. Shi JM, Henry SP, Dwy SL, Orazietti SA, Carroll KM. Randomized pilot trial of 
Web-based cognitive-behavioral therapy adapted for use in office-based 
buprenorphine maintenance. Substance Abuse. 2019;40(2):132-135. 
26. Tetrault JM, Holt SR, Cavallo DA, et al. Computerized Cognitive Behavioral 
Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A 
Randomized Feasibility Trial to Address the RT Component of SBIRT. J Addict 
Med. 2020;14(6):e303-e309. 
27. Jonaki Bose SLH, Rachel N. Lipari, Eunice Park-Lee. 2017 NSDUH Annual 
National Report. Substance Abuse and Mental Health Services Administration 
2018:124. 
28. Carroll K. CBT4CBT, LLC. [Internet]. 2019; Developers of Computer Based 
Training for Cognitive Behavioral Therapy. Available at: https://cbt4cbt.com/. 
Accessed 12/30/2020, 2020`. 
29. Carroll KM, Kiluk BD, Nich C, et al. Cognitive function and treatment response 
in a randomized clinical trial of computer-based training in cognitive-behavioral 
therapy. Subst Use Misuse. 2011;46(1):23-34. 
30. Morie KP, Nich C, Hunkele K, Potenza MN, Carroll KM. Alexithymia level and 
response to computer-based training in cognitive behavioral therapy among 
cocaine-dependent methadone maintained individuals. Drug Alcohol Depend. 
2015;152:157-163. 
31. Kiluk BD, Nich C, Babuscio T, Carroll KM. Quality versus quantity: acquisition 
of coping skills following computerized cognitive-behavioral therapy for 
substance use disorders. Addiction. 2010;105(12):2120-2127. 
32. Levy S, Sherritt L, Harris SK, et al. Test-retest reliability of adolescents' self-
report of substance use. Alcohol Clin Exp Res. 2004;28(8):1236-1241. 
32 
 
33. Measures H. PROMIS.  
https://www.healthmeasures.net/index.php?option=com_content&view=category
&layout=blog&id=147&Itemid=806. Accessed June 9, 2021, 2021. 
34. MacLaren VV, Best LA. Multiple addictive behaviors in young adults: student 
norms for the Shorter PROMIS Questionnaire. Addict Behav. 2010;35(3):252-
255. 
35.  Carroll K. CBT4CBT, LLC. [Internet]. 2019; Developers of Computer Based 
Training for Cognitive Behavioral Therapy. Available at: https://cbt4cbt.com/. 
Accessed 12/30/2020, 2020`. 
 
 
Chapter 3- Study Methods 
3.1 Study Design 
 This will be a multi-site randomized control trial. We will be evaluating the effect 
of CBT4CBT as an adjunctive therapy to standard outpatient care for SUD treatment 
among adolescents and young adults. Our multi-site study will be based out of primary 
care clinics in New Haven county. We will be using a 1:1 randomization to assign 
participants to the intervention or control group, stratifying based on site. Due to the 
nature of the intervention, it will not be possible to blind participants. Thus, the 
assignment given to each subject will be blinded to follow-up assessors. 
3.2 Study Population and Sampling 
 This study will recruit adolescents and young adults visiting their primary care 
office for any type of visit, who are identified to have SUD. These subjects must be 
between the ages of 13-24 and be diagnosed with a SUD based on DSM 5 criteria. 
Eligible candidates will be willing to initiate treatment and not currently engaged in SUD 
treatment. They would also have access to a smart device such as a computer or tablet.  
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3.3 Inclusion Criteria 
Our inclusion criteria will be modeled after a study by Tetrault et al., that 
evaluated CBT4CBT in adults that were identified as having a SUD by their primary 
care clinicians as well as a trial by Sweeney et al., that studied adolescents with 
substance use disorder. Inclusion criteria will be as follows: fluency in English, ability 
to read at 6th grade level, meet the current DSM 5 criteria for substance use disorder, 
access to a smartphone/computer/tablet with internet access, and ages 13-24. 3,4 
 
3.4 Exclusion Criteria  
The exclusion criteria will be: current enrollment in SUD treatment, any 
untreated psychotic disorder, current legal case pending where incarceration is 
possible, any condition where hospitalization is required, active drug withdrawal, or 
any condition with significant cognitive impairment.  3,4 
 
Table 1: Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
• Ages 13-24 
• Fluency in English 
• Ability to read at 6th grade level 
• Meet current DSM V criteria for SUD 
• Access to smart device with internet 
access 
• Guardian consent if under age 18 
• Untreated psychotic disorder 
• Current legal case pending where 
incarceration is possible 
• Required hospitalization 
• Conditions with significant 
impairment 
• Not in active withdrawal  
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• Current enrollment in SUD treatment 
 
3.5 Subject protection and confidentiality 
 Before initiating recruitment, our team will obtain approval from the Yale 
Institutional Review Board. This will be done by applying for approval of the study as 
well as design. The application will be approved before initiating the study. To maintain 
compliance of the Yale IRB, there will be an Authorization and Consent for participation 
in Research Project 200 FR. 1 form. This form includes: invitation to participate, 
description of the project with risks and benefits, treatment alternatives, guidance on 
voluntary participation and withdrawal, confidentiality and privacy agreements, and 
economic considerations.  
 All participants will be required to review the form with a research staff member 
to ensure they understand all procedures, risks and benefits, and provide written consent 
prior to initiating treatment. 
 In addition, all research investigators involved must complete the Health and 
Insurance Portability Accountability Act (HIPPAA) training session. Evidence of 
completion via certificate must be provided to Yale IRB. This will ensure that all 
participants’ identifiable health information will remain protected. All information and 
records throughout this study will be kept on an encrypted computer system, that is only 
accessible by necessary personnel of the study. All personal participant data will be 




This study will recruit individuals from the primary care clinics within the New 
Haven County area. The recruitment technique we will be using in this study will be the 
referral approach. This approach involves having colleagues of the recruitment site giving 
information to potential participants about this study.  Chain referral has a seven-step 
method of sampling:  
8. Defining the population and subjects 
9. Considering the sample size. 
10. Selecting and assessing settings.  
11. Gaining access. 
12. Initiating chains and identifying locators. 
13. Pacing and monitoring of the referral chains. 
14. Discontinuing the referral chains. 2 
This will identify a small set of subjects, who will then be asked to identify and 
recruit more subjects. This will be monitored to insure proper inclusion and exclusion 
criteria.  
3.7 Study Variable and Measures 
The independent variable in our study will be access to the CBT4CBT program as 
an adjunctive therapy to TAU. The control variable will be TAU for all participants with 
no adjunctive therapy.  The TAU will include typical interventions provided within a 
primary care facility, which may include brief intervention and referral to additional 
specialized services. Such specialized services can include: group therapy, individual 
psychotherapy, and/or medications. The dependent and primary outcome for our study is 
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the percentage of urine samples that are negative for substances during the two months of 
treatment.  We will also include urine samples collected within the 6-month period after 
treatment as a secondary outcome. Participants will be screened via urinalysis prior to the 
initiation of treatment, as well as weekly during treatment and at the conclusion of 
treatment, as well as at 1-, 3- and 6-month intervals post treatment. Once participants 
initiate treatment, they will be asked to submit urine samples when they are at the clinic 
for their TAU, as well as asked to come back to submit urine samples after treatment. The 
test will be administered and supervised by a clinician or research assistant. Finally, we 
will examine the engagement in treatment as measured by the number of SUD treatment 
sessions attended and/or CBT4CBT modules completed. 
 
3.8 Methodology Considerations 
 3.8.1 Blinding of Intervention 
 Due to the nature of this study (behavioral intervention), blinding of the 
intervention to each group will not be possible. The investigators will be blinded to the 
allocation of each subject when analyzing the results of the study. Additionally, subjects 
will be asked not to disclose their allocation to any staff. 
 3.8.2 Blinding of Outcome 
 The research staff that is collecting urine samples as well as TLFB results will be 
blinded to allocation of each study participant. The staff within the primary care clinics 
will not be assisting in assessing the study outcomes to ensure the validity and blinding of 
results.   
37 
 
 3.8.3 Assignment of Intervention 
 All participants in the study will be assigned to either the intervention group 
(CBT4CBT+TAU), or control group (TAU) through stratified random sampling. The 
randomization will take place using a computer system that randomly assigns subjects to 
an intervention condition. Stratification will be by age group (13-17 or 18-24) and type of 
substance (cannabis, opioids, other) There will be a 1:1 allocation to the intervention or 
control group. After randomization takes place, each group will be notified of their 
respective intervention placement. 
 3.8.4 Adherence 
 Adherence for the group assigned to the CBT4CBT intervention will be 
monitored through the CBT4CBT program, which tracks for each participant the number 
of modules completed, and number of minutes engaged with the program. Additionally, 
adherence to TAU will be monitored via staff administering this treatment. Treatment 
completion will be defined as attending a minimum of 70% of the sessions for CBT4CBT 
as well as TAU. For CBT4CBT this will require completing 5/7 modules. If participants 
are prescribed medication to assist in treating their SUD, this will be assessed each time 
the participant gives a urine sample.  
To encourage adherence, travel expenses for TAU will be reimbursed. 
Additionally, participants will receive $5 for each TAU session that is attended.  
Participants assigned to CBT4CBT will be given a $50 bonus for completing all 7 
CBT4CBT modules, consistent with procedures from prior trials of CBT4CBT.  Finally, 
to encourage participants to submit urine samples, participants will be given a ticket each 
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time they submit a urine sample that will be entered in a raffle at the end of the study 
worth $150.  
3.9 Data Collection 
 Primary and secondary outcomes will be collected for a total of 8 months (2-
month treatment period plus 6-month follow-up). Data will begin to be collected at the 
initiation of treatment and every week subsequently after during the treatment period. 
Urine screens will continue after treatment for 6 months at the 1-, 3- and 6-month 
intervals. Once participants initiate treatment, they will be asked to submit urine samples 
when they are at the clinic for their TAU, as well as asked to come back to submit urine 
samples after treatment. The test will be administered and supervised by a clinician or 
research assistant. 
 Secondary outcomes for our analysis will assess the percentage of days during 
treatment that the participant uses drugs, or frequency of drug use. This outcome will be 
assessed through self- reporting, utilizing the TLFB. The TLFB will be administered at 
the same time as every urine specimen is given, as the urine specimen will validate the 
self- report.  We will also measure engagement in treatment, as measured by the number 
of SUD treatment sessions attended and/or CBT4CBT modules completed throughout the 
eight-week period. Additional secondary outcomes include instruments from the Patient 
Reported Outcomes Measurement Information System. We will utilize three of these 
measures: Emotional and Behavioral Dyscontrol, Self-Efficacy, and Severity of 
Substance Use. The survey for Emotional and Behavioral Dyscontrol will be given 
weekly along with the TLFB. Both the Self-Efficacy and Severity of Substance Use 
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questionnaires will be given at the beginning of the study and the end of treatment. 
Results from all three surveys will be scored and evaluated by a research technician.  
3.10 Sample Size Collection 
 After evaluating the literature, utilizing similar previous studies of CBT4CBT that 
matches our study design, outcomes and intervention, we estimated a cohen’s d effect 
size of 0.46 utilizing the SocStatistics calulator, which translates to a moderate effect 
size.   
Ultimately, a prospective, randomized clinical trial study found that the 
association between relapse rates and CBT4CBT treatments was significant, where 
participants being treated with CBT4CBT submitted 34% of their total urine specimens 
positive for substances within the time of treatment and the subjects in the control group 
had a result of 53% of their total urine specimens positive for substances during the 
treatment time. 1 Using this effect size of 0.46, a 2-sided significance level of 0.05, and 
an 80% power, we calculated a minimum sample size of 150 utilizing the Power and 
Precision software.      
Our sample size calculation was determined primarily by the results of Carroll et 
al., with additional considerations from Sweeney et al.  In Carroll et al.’s original study 
on CBT4CBT, they found that participants being treated with CBT4CBT submitted 34% 
of their total urine specimens positive for substances within the 8-week treatment and the 
subjects in the control group had a result of 53% of their total urine specimens positive 
for substances during the treatment time. 1 Considering the standard deviations and 
sample sizes, and a moderate effect size (cohen’s d effect size of 0.46),  75 participants 




 All statistical analyses will be performed by the research personnel that are 
completely blinded to the groups each participant was allocated to. Data will be analyzed 
with intention to treat, based on each participant’s original group allocation, regardless of 
their attendance in treatment. For this study, statistical significance will be defined as 
p<0.05 for all measurements. The primary outcome will be the mean percentage of 
negative urine samples over the 8-week treatment period reported as a continuous 
variable.  This will be calculated with two sets of data. One data set will not include 
missed urine samples, and the second will include all urine samples that were intended to 
be collected (i.e., any missing will be deemed positive). Results with be compared with 
ANCOVA test for two unpaired variables. Primary outcome will be evaluated at the 
aforenoted intervals, whether participants adhered to their treatment. Analyses of 
secondary outcomes will also be compared via ANCOVA using continuous variables 
(e.g., number of treatment sessions attended, percentage of self-reported days of 
abstinence, scores on PROMIS measures). 
 There are multiple baseline characteristics of each subject that will be compared 
to ensure that there is limited variation between the intervention and control groups. 
Continuous variables such as age will be reported as a mean and standard deviation and 
compared via ANCOVA. Categorical variables such as gender, race and socioeconomic 
status will be compared using chi square test. If there is a difference between the control 
and intervention groups, we will then use ANCOVA (Analysis of CoVariance) to control 
for these covariates. 
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3.12 Timeline and Resources 
 The proposed study will be completed within the allotted 36-month time frame. 
The initial step in this process will be obtaining IRB approval. We will allocate 3 months 
for this process. Additionally, all research staff will attend a mandatory multi-day training 
to prepare for the study and ensure a standardized experience for each participant. 
Training will begin immediately after IRB approval. We will allocate one month for this, 
assuming we will be able to recruit 8-9 participants per month as we have multiple 
recruitment sites. Participant enrollment will then occur from months 4-22. After 18 
months, enrollment will stop and data collection will continue for 8 months after each 
participant begins treatment. This ensures that participants enrolled on the last day of 
enrollment will be able to submit urine samples for the required 6 months after the 2 
months of treatment. After 30 months when all data is collected, 6 months will be used to 
analyze the data by research staff.  
 Resources required will include: a research coordinator to recruit, consent, screen, 
and enroll participants, a research coordinator familiar with CBT4CBT to inform 
participants about this intervention and assist if questions arise, a research assistant to 
collect data (including urine samples) during the treatment period and follow-up and 
finally a research analyst to gather and organize data. At the conclusion of this study, all 
blinded research analysts will assist in data entry and calculations. Additionally, 
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Chapter 4: Conclusion 
4.1 Advantages and Disadvantages: 
 Our proposed study will be the first of its kind to offer CBT4CBT, a validated 
adjunctive therapy for SUD, to adolescents and young adults. Aside from its novelty, the 
strength of our study aligns with those of previous studies utilizing CBT4CBT. Its 
effectiveness, along with compensation for attendance will ensure adequate intervention 
and control adherence utilizing monetary awards. Additionally, our study design and 
methodology will promote internal validity. The researchers will be blinded, and 
stratified randomization and allocation concealment will limit the amount of selection 
bias and ensure baseline characteristics are similar in potential confounding variables. 
Additionally, a multi-site approach using chain referral sampling and provider 
recommendations will allow us to draw from a large population. Previous similar studies 
have often been limited by their low sample size. Additionally, the given location of New 
Haven County will offer a diverse participant population as over 60% of the population is 
black or Hispanic. 48 
 To address the limitations of our study, we know that the path for many to 
treatment is difficult. As participation in our study will be on a volunteer basis, we will 
face bias among participants who are more willing to continue with treatment than others. 
Additionally, previous studies have had high loss of follow up to treatment. While we do 
account for loss to follow up in our sample size calculation and try to reduce this with a 
compensation plan, it is difficult to predict and mitigate this problem. Lastly, our study’s 
location sites are in an urban area where access to providers and treatment for SUD is 
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relatively high. Due to this, our findings may not generalize adequately to a more rural 
population where these services are less accessible.  
4.2 Clinical and/or Public Health Significance:  
 Research is urgently needed to understand how to provide adequate and 
accessible treatment for young adults and adolescents with SUDs. The proposed study 
will address this critical gap in the literature by demonstrating how to provide 
empirically-validated care that addresses current barriers for this population. Beyond 
access to care, treatment of SUDs can result in lower rates of comorbidities related to 
SUD as well as incidence of death from overdose. If this intervention is successful, it can 
provide insight on how CBT4CBT can be incorporated into treating this population for 
SUD in the future. Additionally, this study can be a basis for future studies to provide 
evidence based adjunctive treatment for adolescents and young adults with SUDs. 
4.3 References: 
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Volunteers Needed for Research Study! 
Are you a young adults or adolescent who uses drugs or alcohol, looking for 
treatment? 
We are conducting a research study to investigate whether utilizing a computer based 
cognitive behavioral therapy in addition to typical treatment can help reduce the use of 
drugs or alcohol in young adults and adolescents with substance use disorders. 
Who can join the study? 
• People ages 13-23 
• People with a substance use disorder seeking treatment 
• Must have access to a device with internet access 
What do you have to do? 
• Access a computer-based program to participate in short weekly modules for 2 months 
• Provide information about your experience with the program 
• Be willing to submit urine samples each week during treatment, and multiple times after treatment 
for 6 months 
Do you get anything in return? 
• Participants will be given $5 for each CBT4CBT module they complete.  
• $50 reward for attending the typical treatments required 
• Entry to a $150 raffle for each urine sample submitted 
To learn more or to determine if you are eligible please email us at: kidsCBT4CBT@yale.edu or call 






Appendix B: Compound Consent and Privacy Rule Authorization Form 
 
 
CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT 
200 FR. 1 (2016-2)  
 
YALE UNIVERSITY SCHOOL OF MEDICINE – YALE-NEW HAVEN  
 
Study Title: Computerized Cognitive Behavioral Therapy in Adolescents and Young 
Adults With Substance Use Disorder 
Principal Investigator: Brian Kiluk, PHD 
 
Invitation to Participate and Description of Project 
 
You are invited to participate in a research study designed to look at the effects of using 
CBT4CBT as an adjunctive therapy to standard treatment for young adults and adolescents 
with substance use disorder. You have been asked to participate because you have met the 
inclusion criteria as an adolescent or young adult with a DSM-V diagnosed Substance Use 
Disorder, seeking initial treatment.  
 
In order to decide whether or not you wish to be a part of this research study you should 
know enough about its risks and benefits to make an informed decision.  This consent form 
gives you detailed information about the research study, which a member of the research 
team will discuss with you.  This discussion should go over all aspects of this research: its 
purpose, the procedures that will be performed, any risks of the procedures, possible 
benefits and possible alternative treatments. Once you understand the study, you will be 
asked if you wish to participate; if so, you will be asked to sign this form. 
 
Description of Procedures 
 
If you agree to participate in this study, our research coordinator will ask you questions 
regarding your risk behaviors, and demographics. We will be collecting information such 
as age, sex, gender identity, sexual orientation, history of substance use, psychiatric and 
medical history, race, education, income, employment status, insurance and transportation 
needs. 
 
You will then be randomly assigned to receive (1) CBT4CBT access with standard 
treatment or (2) standard treatment. All participants will receive standard treatment 
regardless of allocation. Randomization occurs through a computer-based system in which 
you have equal chances of being allocated to either group. Once you have been assigned 
to the group, you will have a unique study code to identify you without bias throughout the 
study.  
If you are assigned to the CBT4CBT intervention group, you will be asked to speak with a 
CBT4CBT moderator to answer any questions and learn about the program. After, you will 
be asked to complete as many of the CBT4CBT modules as you can, one per week for 8 
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weeks. Each module will take 30-60 minutes. Both groups will be asked to attend 
standardized treatment recommended by a physician (group therapy, medication assisted 
treatment.) 
 
Research staff will contact you by phone to submit urine samples weekly at standardized 
treatment for the initial 8 weeks, and then again at the 1, 3 and 6 months intervals after 
finishing the intervention. You will also be asked to self report substance use, utilizing the 
TLFB screen prior to each submission of urine.  
 
A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as 
required by U.S. Law. This Web site will not include information that can identify you. 
At most, the Web site will include a summary of the results. You can search this Web site 
at any time. You will be told of any significant new findings that are developed during 
the course of your participation in this study that may affect your willingness to continue 
to participate. If research results are published, your name and personal information will 
remain confidential. 
 
Risks and Inconveniences 
 
Guidelines: 
There are no physical risks associated with this study.  However, some questions may make 
you uncomfortable and there is the possible risk of loss of confidentiality.  Every effort 
will be made to keep your information confidential; however, this cannot be guaranteed. 




The potential benefits of this study are connection to treatment for SUD and the initiation 
of CBT4CBT, which can significantly reduce the use of substances. 
 
Economic Considerations 
There are no costs associated with participation in the study. However, you may be 
responsible for costs associated with standard treatment or transportation. According to 
the rules of the Internal Revenue Service (IRS), payments that are made to you as a result 
of your participation in a study may be considered taxable income. To encourage 
adherence, travel expenses for TAU will be reimbursed. Additionally, all patients will be 
given $5 for each CBT4CBT module they complete. To encourage participants to attend 
TAU, they will receive $50 at the end of the study if they complete at least 70% of the 
sessions recommended. Finally, to encourage patient to submit urine samples, 
participants will be given a ticket each time they submit a urine sample to submit for a 
raffle at the end of the study worth $150.  
 
Treatment Alternatives/Alternatives 
If you choose not to participate in this study, there are alternative treatments available. 





Any identifiable information that is obtained in connection with this study will remain 
confidential and will be disclosed only with your permission or as required by U.S. or State 
law.  Examples of information that we are legally required to disclose include abuse of a 
child or elderly person, or certain reportable diseases. When the results of the research are 
published or discussed in conferences, no information will be included that would reveal 
your identity unless your specific consent for this activity is obtained.  Information will be 
kept confidential by using no patient identifiers on forms, and keeping all information 
locked. When the results of this study are published, no information will be included to 
reveal your identity.  
 
Voluntary Participation and Withdrawal 
Participating in this study is voluntary. You are free to choose not to take part in this 
study.   Refusing to participate will involve no penalty or loss of benefits to which you 
are otherwise entitled (such as your health care outside the study, the payment for your 
health care, and your health care benefits).  However, you will not be able to enroll in this 
research study and will not receive study procedures as a study participant if you do not 
allow use of your information as part of this study. 
 
If you do become a subject, you are free to stop and withdraw from this study at any time 
during its course. To withdraw from the study, you can call a member of the research 
team at any time and tell them that you no longer want to take part.  This will cancel any 
future appointments. Withdrawing from the study will involve no penalty or loss of 
benefits to which you are otherwise entitled.  It will not harm your relationship with your 
own doctors. We would still treat you with standard therapy or, at your request, refer you 
to a clinic or doctor who can offer this treatment. 
 
When you withdraw from the study, no new health information identifying you will be 
gathered after that date.  Information that has already been gathered may still be used and 
given to others until the end of the research study, as necessary to insure the integrity of 
the study and/or study oversight.   
 
Questions 
We have used some technical terms in this form.  Please feel free to ask about anything 
you don't understand and to consider this research and the consent form carefully – as long 






I have read (or someone has read to me) this form and have decided to participate in the 
project described above.  Its general purposes, the particulars of my involvement and 
possible hazards and inconveniences have been explained to my satisfaction.  My signature 







      










Signature of Principal Investigator  Date 
  
                                      or 
 
___________________________________________ ___________________ 
Signature of Person Obtaining Consent  Date 
 
 
If you have further questions about this project or if you have a research-related problem, 
you may contact the Principal Investigator. 
If, after you have signed this form you have any questions about your privacy rights, 
please contact the Yale Privacy Officer at 203-432-5919. If you would like to talk with 
someone other than the researchers to discuss problems, concerns, and questions you may 
have concerning this research, or to discuss your rights as a research subject, you may 
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Name/ID#: ________________________________________ Date:___________________ 
 













SUN MON TUES WED THURS FRI SAT 




J 2 3 4 5 6 Epiphany 7 8 
A 9 10 11 12 13 14 15 
N 16 17
 M.Luther King  
Day 
18 19 20 21 22 
 23 24 25 26 27 28 29 
 30 31 1 2 3 4 5 
Complete the Following 
 
Start Date (Day 1):   End Date (yesterday):  
  ___ 
MO DY  YR       MO





F 6 7 8 9




10 11 12 




15 16 17 18 19  
B 20 21 
Presidents’ 
Day 
22 23 24 25 26 
 27 28 1 2 3 4 5 
M 6 7 8 9 10 11 12 






R 20 21 22 23 24 25  26 
 27  28 29 30 31 1 2 
A 3 4 5 6 7 8 9 
P 10 11 12
 












 25 26 27 28 29 30 
M 1 2 3 4 5 6 7 
A 8 
Mother’s Day
 9 10 11 12 13 14 
Y 15
  16 17 18 19 20 21 
 22 23 24 25 26 27 28 
 29 30 







SUN MON TUES WED THURS FRI SAT 
    1 2 3 4 
J 5 6 7 8 9 10 11 





20 21 22 23 24 25 
 26 27 28 29 30 1 2 





5 6 7 8 9 
U 10 11 12 13 14 15 16 
L 17 18 19 20 21 22 23 
 24 25 26 27 28 29 30 
 31 1  2 3 4 5 6 
A 7 8 9 10 11 12 13 
U 14 15 16 17 18 19 20 
G 21 22 23 24 25 26 27 
 28 29 30 31 1 2 3 
S 4 5 Labor Day 6 7 8 9 10 
E 11 12 13 14 15
 
 16 17 
P 18 19 20 21 22 23 24
 
 
 25 26 27 28 29 30 1 
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11 12 13 
Yom Kippur
 14 15 
T 16 17 18 19 20 21 22 
 23 24 25 26 27 28 29 




 2 3 4 5 




O 13 14 15 16 17 18 19 






 27 28 29 30 1 2 3 
D 4 5 6 7  8 9 10 
E 11 12 13 14 15 16 17 
C 18 19 20 21 22 23 24
 
 




 27 28 29 30 31 
 
Instructions for filling out TLFB calendar: 
To help us evaluate your drug use, we need to get an idea of what your use was like in the 
past ____ days. To do this, we would like you to fill out the attached calendar. \ 
 Filling out the calendar is not hard!  
Try to be as accurate as possible.  
We recognize you won’t have perfect recall. That’s OKAY.  
 WHAT TO FILL IN  
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• The idea is that for each day on the calendar we want you to indicate whether you 
“used" or “did not use” drugs.  
• On days when you did not use drugs, you should write a “0” in the box.  
• On days when you did use drugs, you should put a “” in the box. It’s important that 
something is written for every day, even if it is a “0”.  YOUR BEST ESTIMATE • We 
realize it isn’t easy to recall things with 100% accuracy. 
 • If you are not sure whether you used a certain drug on a Thursday or a Friday of a 
certain week, give it your best guess! The goal is to get a picture of how many days you 
were using drugs and your patterns of use. 
HELPFUL HINTS  
• Holidays such as Thanksgiving and Christmas are marked on the calendar to help you 
better recall your use. Also, think about whether you used drugs on personal holidays and 
events such as birthdays, vacations, or parties.  
• If you have regular drug use patterns you can use these to help you recall your use. For 
example, you may have weekend/weekday changes in your drug use or your drug use 
may be different depending where you are or whom you are with.  
COMPLETING THE CALENDAR  
• A blank calendar is attached. Each day should contain a "0" for no drug use or a "" for 
drug use.  
• The time period we are talking about on the calendar is from 
________________________ to _______________________.  
• In estimating your drug use, be as accurate as possible. 
















































Appendix G: Sample Size Calculation 
The following calculation was made using the Power and Precision Version 4 tool: 
Two-tailed test: Alpha (level of significance) = 0.05, B (type II error) = 0.20, 
corresponding to a power of 80% 
For a given cohen’s d effect size of 46% (population proportions of 53 vs. 34 and 
standard deviation of 41), sample sizes (75 and 75), and alpha (0.05, 2-tailed), power is 
0.80. This means that 80% of studies would be expected to yield a significant effect, 




Standard deviation (s): 41
 





Standard deviation (s): 40.9
 
Sample size (n): 26
 
Calculate




Cohen's d = (34 - 53) ⁄ 40.950031 = 0.46398. 
Glass's delta = (34 - 53) ⁄ 41 = 0.463415. 
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